Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Targeted next-generation sequencing (NGS) is a rapid and accurate solution for microbial genomes, suitable for bacterial and viral typing, epidemiological studies, and disease surveillance.
Ion AmpliSeq targeted NGS panels run on the Ion Torrent Genexus Integrated Sequencer provide an ultra-highly sensitive, rapid, and accessible solution for infectious disease researchers.
Request project costs Request virtual demo
Download flyer: Genexus Integrated Sequencer for SARS-CoV-2 research and beyond ››
Ion Torrent NGS technology is based on ultrahigh-multiplex PCR, the same technology that has enabled public health agencies to closely monitor viral infections.
Benefits of using targeted NGS and the Genexus Integrated Sequencer for studying infectious diseases include:
The new Ion AmpliSeq SARS-CoV-2 Insight Research Assay* for the Genexus Integrated Sequencer enables complete viral genome sequencing and variant detection of SARS-CoV-2 with >99% coverage.
Please fill out the project cost request form to inquire about ordering the Genexus Integrated Sequencer.
For Research Use Only. Not for use in diagnostic procedures.